Novo Nordisk recognizes that some patients find it difficult to pay for healthcare, including insulin. As such, the company remains committed to reducing the burden of out-of-pocket costs, helping transform the complex pricing system, and fostering better pricing predictability. Novo Nordisk continually reviews and revises our offerings and works with diverse stakeholders to create solutions for differing patient needs.
Partnered with Walmart to create a Human Insulin Program
2000
For over 2 decades, ReliOn™ Novolin® has been available in the market for under $25 per vial
2000
Partnered with Walmart to create a Human Insulin Program
For over 2 decades, ReliOn™ Novolin® has been available in the market for under $25 per vial
Global access to care strategy
2001
Established the global access to care strategy, a ground-breaking policy to lower the cost of insulin in low-income countries
2001
Global access to care strategy
Established the global access to care strategy, a ground-breaking policy to lower the cost of insulin in low-income countries
Patient Assistance Program
2003
Launched our Patient Assistance Program to offer free diabetes products to eligible low-income patients
2003
Patient Assistance Program
Launched our Patient Assistance Program to offer free diabetes products to eligible low-income patients
Limit price increases
2016
Pledged to limit any potential list price increases to single digits annually
2016
Limit price increases
Pledged to limit any potential list price increases to single digits annually
Access to Insulin Commitment
2016
Initiated the Access to Insulin Commitment designed to lower the ceiling price and include humanitarian relief settings, while guaranteeing low-priced human insulin for patients in underprivileged regions of the world for many years to come
2016
Access to Insulin Commitment
Initiated the Access to Insulin Commitment designed to lower the ceiling price and include humanitarian relief settings, while guaranteeing low-priced human insulin for patients in underprivileged regions of the world for many years to come
Novo Nordisk Novolin®
2017
Worked with CVS to make Novo Nordisk Novolin® available to patients for $25 per vial
2017
Novo Nordisk Novolin®
Worked with CVS to make Novo Nordisk Novolin® available to patients for $25 per vial
NovoCare®
2017
Launched NovoCare®, a single destination for all branded savings/copay offers, other affordability programs and educational resources
2017
NovoCare®
Launched NovoCare®, a single destination for all branded savings/copay offers, other affordability programs and educational resources
ReliOn™ Novolin®
2018
Made ReliOn™ Novolin® insulin pens available at Walmart
2018
ReliOn™ Novolin®
Made ReliOn™ Novolin® insulin pens available at Walmart
Immediate Supply
2020
Established Immediate Supply: A one-time free short-term supply of insulin (up to 3 vials or 2 packs of pens) to eligible patients at risk of rationing
2020
Immediate Supply
Established Immediate Supply: A one-time free short-term supply of insulin (up to 3 vials or 2 packs of pens) to eligible patients at risk of rationing
COVID-19 Patient Assistance Program
2020
Created the COVID-19 Patient Assistance Program: Offers 90 days of free insulin to eligible patients who lost healthcare coverage due to COVID-19 job loss.
*Program ended 12/31/2022
2020
COVID-19 Patient Assistance Program
Created the COVID-19 Patient Assistance Program: Offers 90 days of free insulin to eligible patients who lost healthcare coverage due to COVID-19 job loss.
*Program ended 12/31/2022
Unbranded Biologics
2020
Introduced unbranded biologics, Insulin Aspart and Insulin Aspart Protamine/Insulin Aspart available at 50% off the list price of NovoLog® and NovoLog® Mix 70/30
2020
Unbranded Biologics
Introduced unbranded biologics, Insulin Aspart and Insulin Aspart Protamine/Insulin Aspart available at 50% off the list price of NovoLog® and NovoLog® Mix 70/30
My$99Insulin Offer
2020
Established My$99Insulin: A monthly supply of any combination of Novo Nordisk insulin products for eligible patients (up to 3 vials or 2 packs of FlexPen® /FlexTouch® /PenFill® pens) for $99. This program was replaced by MyInsulinRx™ in 2023
2020
My$99Insulin Offer
Established My$99Insulin: A monthly supply of any combination of Novo Nordisk insulin products for eligible patients (up to 3 vials or 2 packs of FlexPen® /FlexTouch® /PenFill® pens) for $99. This program was replaced by MyInsulinRx™ in 2023
ReliOn™ NovoLog® and NovoLog® Mix 70/30
2021
Launched ReliOn™ NovoLog® and NovoLog® Mix 70/30 available at Walmart
2021
ReliOn™ NovoLog® and NovoLog® Mix 70/30
Launched ReliOn™ NovoLog® and NovoLog® Mix 70/30 available at Walmart
Unbranded Biologic
2022
Made unbranded biologic, Insulin Degludec available at 65% off the list price of Tresiba®
2022
Unbranded Biologic
Made unbranded biologic, Insulin Degludec available at 65% off the list price of Tresiba®
MyInsulinRxTM
2023
Created MyInsulinRxTM: A monthly supply of any combination of Novo Nordisk insulin products for eligible patients (up to 3 vials or 2 packs of FlexPen®/FlexTouch®/PenFill® pens) for $35
2023
MyInsulinRxTM
Created MyInsulinRxTM: A monthly supply of any combination of Novo Nordisk insulin products for eligible patients (up to 3 vials or 2 packs of FlexPen®/FlexTouch®/PenFill® pens) for $35
Insulin Price Reduction
2024
Novo Nordisk lowered U.S. prices of for selected insulin brands by up to 75% off
2024
Insulin Price Reduction
Novo Nordisk lowered U.S. prices of for selected insulin brands by up to 75% off
We encourage anyone in need to go to NovoCare.com to learn more.
Copay and Patient Assistance Program offerings:
Copay Savings Cards: Copays for as little as $35 for several insulin products for eligible patients with commercial insurance plans
Patient Assistance Program: Offers free diabetes medication to people in need who meet certain eligibility criteria
